![](/img/cover-not-exists.png)
Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus
Sha, S., Polidori, D., Heise, T., Natarajan, J., Farrell, K., Wang, S.-S., Sica, D., Rothenberg, P., Plum-Mörschel, L.Volume:
16
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12322
Date:
November, 2014
File:
PDF, 605 KB
english, 2014